118 related articles for article (PubMed ID: 27307090)
1. MicroPET/CT assessment of FDG uptake in brain after long-term methylphenidate treatment in nonhuman primates.
Zhang X; Newport GD; Callicott R; Liu S; Thompson J; Berridge MS; Apana SM; Slikker W; Wang C; Paule MG
Neurotoxicol Teratol; 2016; 56():68-74. PubMed ID: 27307090
[TBL] [Abstract][Full Text] [Related]
2. MicroPET/CT assessment of neurochemical effects in the brain after long-term methylphenidate treatment in nonhuman primates.
Zhang X; Talpos J; Berridge MS; Apana SM; Slikker W; Wang C; Paule MG
Neurotoxicol Teratol; 2021; 87():107017. PubMed ID: 34265415
[TBL] [Abstract][Full Text] [Related]
3. Discontinuation of methylphenidate after long-term exposure in nonhuman primates.
Zhang X; Berridge MS; Apana SM; Slikker W; Paule MG; Talpos J
Neurotoxicol Teratol; 2023; 97():107173. PubMed ID: 36893929
[TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates.
Gill KE; Pierre PJ; Daunais J; Bennett AJ; Martelle S; Gage HD; Swanson JM; Nader MA; Porrino LJ
Neuropsychopharmacology; 2012 Nov; 37(12):2555-65. PubMed ID: 22805600
[TBL] [Abstract][Full Text] [Related]
5. Methylphenidate increases glucose uptake in the brain of young and adult rats.
Réus GZ; Scaini G; Titus SE; Furlanetto CB; Wessler LB; Ferreira GK; Gonçalves CL; Jeremias GC; Quevedo J; Streck EL
Pharmacol Rep; 2015 Oct; 67(5):1033-40. PubMed ID: 26398400
[TBL] [Abstract][Full Text] [Related]
6. Methylphenidate increases creatine kinase activity in the brain of young and adult rats.
Scaini G; Fagundes AO; Rezin GT; Gomes KM; Zugno AI; Quevedo J; Streck EL
Life Sci; 2008 Dec; 83(23-24):795-800. PubMed ID: 18938183
[TBL] [Abstract][Full Text] [Related]
7. Methylphenidate clinically oral doses improved brain and heart glutathione redox status and evoked renal and cardiac tissue injury in rats.
Loureiro-Vieira S; Costa VM; Duarte JA; Duarte-Araújo M; Gonçalves-Monteiro S; Maria de Lourdes B; Carvalho F; Capela JP
Biomed Pharmacother; 2018 Apr; 100():551-563. PubMed ID: 29482048
[TBL] [Abstract][Full Text] [Related]
8. The effects of chronic methylphenidate administration on operant test battery performance in juvenile rhesus monkeys.
Rodriguez JS; Morris SM; Hotchkiss CE; Doerge DR; Allen RR; Mattison DR; Paule MG
Neurotoxicol Teratol; 2010; 32(2):142-51. PubMed ID: 19737611
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic methylphenidate in adolescence on later methylphenidate self-administration in rhesus monkeys.
Martelle SE; Porrino LJ; Nader MA
Behav Pharmacol; 2013 Sep; 24(5-6):478-81. PubMed ID: 23903242
[TBL] [Abstract][Full Text] [Related]
10. 1H MRS-detectable metabolic brain changes and reduced impulsive behavior in adult rats exposed to methylphenidate during adolescence.
Adriani W; Canese R; Podo F; Laviola G
Neurotoxicol Teratol; 2007; 29(1):116-25. PubMed ID: 17196789
[TBL] [Abstract][Full Text] [Related]
11. Does chirality matter? pharmacodynamics of enantiomers of methylphenidate in patients with attention-deficit/hyperactivity disorder.
Quinn D
J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S62-6. PubMed ID: 18480679
[TBL] [Abstract][Full Text] [Related]
12. Chronic methylphenidate preferentially alters catecholamine protein targets in the parietal cortex and ventral striatum.
Quansah E; Zetterström TSC
Neurochem Int; 2019 Mar; 124():193-199. PubMed ID: 30660754
[TBL] [Abstract][Full Text] [Related]
13. Increased brain metabolism after acute administration of the synthetic cannabinoid HU210: a small animal PET imaging study with 18F-FDG.
Nguyen VH; Verdurand M; Dedeurwaerdere S; Wang H; Zahra D; Gregoire MC; Zavitsanou K
Brain Res Bull; 2012 Feb; 87(2-3):172-9. PubMed ID: 22155282
[TBL] [Abstract][Full Text] [Related]
14. Methylphenidate treatment induces oxidative stress in young rat brain.
Martins MR; Reinke A; Petronilho FC; Gomes KM; Dal-Pizzol F; Quevedo J
Brain Res; 2006 Mar; 1078(1):189-97. PubMed ID: 16494852
[TBL] [Abstract][Full Text] [Related]
15. A minimally invasive, translational biomarker of ketamine-induced neuronal death in rats: microPET Imaging using 18F-annexin V.
Zhang X; Paule MG; Newport GD; Zou X; Sadovova N; Berridge MS; Apana SM; Hanig JP; Slikker W; Wang C
Toxicol Sci; 2009 Oct; 111(2):355-61. PubMed ID: 19638431
[TBL] [Abstract][Full Text] [Related]
16. Methylphenidate differentially regulates c-fos and fosB expression in the developing rat striatum.
Chase TD; Carrey N; Brown RE; Wilkinson M
Brain Res Dev Brain Res; 2005 Jun; 157(2):181-91. PubMed ID: 15916815
[TBL] [Abstract][Full Text] [Related]
17. Chronic treatment and abstinence from methylphenidate exposure dose-dependently changes glucose metabolism in the rat brain.
Richer K; Hamilton J; Delis F; Martin C; Fricke D; Yao R; Sajjad M; Blum K; Hadjiargyrou M; Komatsu D; Thanos PK
Brain Res; 2022 Apr; 1780():147799. PubMed ID: 35074404
[TBL] [Abstract][Full Text] [Related]
18. Superoxide production after acute and chronic treatment with methylphenidate in young and adult rats.
Gomes KM; Inácio CG; Valvassori SS; Réus GZ; Boeck CR; Dal-Pizzol F; Quevedo J
Neurosci Lett; 2009 Nov; 465(1):95-8. PubMed ID: 19716398
[TBL] [Abstract][Full Text] [Related]
19. Exposure to oral methylphenidate from adolescence through young adulthood produces transient effects on hippocampal-sensitive memory in rats.
Bethancourt JA; Camarena ZZ; Britton GB
Behav Brain Res; 2009 Aug; 202(1):50-7. PubMed ID: 19447280
[TBL] [Abstract][Full Text] [Related]
20. A PET study examining pharmacokinetics and dopamine transporter occupancy of two long-acting formulations of methylphenidate in adults.
Spencer TJ; Bonab AA; Dougherty DD; Martin J; McDonnell T; Fischman AJ
Int J Mol Med; 2010 Feb; 25(2):261-5. PubMed ID: 20043136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
